These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20865359)

  • 1. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies.
    Oliveira Frick V; Rubie C; Ghadjar P; Faust SK; Wagner M; Gräber S; Schilling MK
    Tumour Biol; 2011 Feb; 32(1):189-96. PubMed ID: 20865359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
    Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
    Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
    Rubie C; Frick VO; Wagner M; Schuld J; Gräber S; Brittner B; Bohle RM; Schilling MK
    BMC Cancer; 2008 Jun; 8():178. PubMed ID: 18578857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential CXC receptor expression in colorectal carcinomas.
    Rubie C; Kollmar O; Frick VO; Wagner M; Brittner B; Gräber S; Schilling MK
    Scand J Immunol; 2008 Dec; 68(6):635-44. PubMed ID: 18959627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases.
    Rubie C; Frick VO; Wagner M; Weber C; Kruse B; Kempf K; König J; Rau B; Schilling M
    World J Gastroenterol; 2006 Nov; 12(41):6627-33. PubMed ID: 17075975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.
    Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Faust SK; Vicinus B; Gräber S; Kollmar O; Schilling MK
    J Transl Med; 2011 Feb; 9():22. PubMed ID: 21349176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SDF-1/CXCR4 axis promotes directional migration of colorectal cancer cells through upregulation of integrin αvβ6.
    Wang B; Wang W; Niu W; Liu E; Liu X; Wang J; Peng C; Liu S; Xu L; Wang L; Niu J
    Carcinogenesis; 2014 Feb; 35(2):282-91. PubMed ID: 24085800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
    Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of IL-8 with induction, progression and metastatic potential of colorectal cancer.
    Rubie C; Frick VO; Pfeil S; Wagner M; Kollmar O; Kopp B; Graber S; Rau BM; Schilling MK
    World J Gastroenterol; 2007 Oct; 13(37):4996-5002. PubMed ID: 17854143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of chemokine receptor CCR6 in colorectal cancer metastasis.
    Rubie C; Oliveira V; Kempf K; Wagner M; Tilton B; Rau B; Kruse B; Konig J; Schilling M
    Tumour Biol; 2006; 27(3):166-74. PubMed ID: 16641550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis.
    Matsusue R; Kubo H; Hisamori S; Okoshi K; Takagi H; Hida K; Nakano K; Itami A; Kawada K; Nagayama S; Sakai Y
    Ann Surg Oncol; 2009 Sep; 16(9):2645-53. PubMed ID: 19588204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of clock gene expression in human colorectal liver metastases.
    Huisman SA; Ahmadi AR; IJzermans JN; Verhoef C; van der Horst GT; de Bruin RW
    Tumour Biol; 2016 Oct; 37(10):13973-13981. PubMed ID: 27492458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
    Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
    Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Patterns of CXCL12 and its Receptor in Colorectal Carcinoma.
    Mousavi A; Hashemzadeh S; Bahrami T; Estiar MA; Feizi MAH; Pouladi N; Rostamizadeh L; Sakhinia E
    Clin Lab; 2018 May; 64(5):871-876. PubMed ID: 29739049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
    Kim J; Mori T; Chen SL; Amersi FF; Martinez SR; Kuo C; Turner RR; Ye X; Bilchik AJ; Morton DL; Hoon DS
    Ann Surg; 2006 Jul; 244(1):113-20. PubMed ID: 16794396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
    Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
    Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
    Yoshida D; Koketshu K; Nomura R; Teramoto A
    J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.